Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDRH Logs 226 More 510(k)s In FY 2002; Review Times Slip Four Days

This article was originally published in The Gray Sheet

Executive Summary

CDRH issued 134 decisions for Class III 510(k)s in FY 2002, 30 more than in FY 2001, according to preliminary counts by the device center

You may also be interested in...



CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

CDRH Medical/Scientific Hiring Is In Partial Limbo, Awaits Approps

CDRH's Office of Device Evaluation began fiscal 2003 with six fewer medical officers and three fewer scientific reviewers than in the previous year, according to the 1ODE's FY 2002 annual report

Fewer 510(k) Outliers Expected With User Fees; FDA Offers Guide To MDUFMA

Device user fee implementation is not expected to have a significant near-term impact on average premarket notification review times, according to CDRH staffers, although the fees may help rein in times for "outliers," 510(k)s that take an unusually long time to review

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017288

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel